EJP PHARMACEUTICAL ApS
CVR 87923614 · Private limited company (ApS) · Active · Low risk
EJP PHARMACEUTICAL ApS is a Private limited company (ApS), founded on , based in Skodsborg. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 814k and a net result of DKK 214k. CEO: Ejvind Jersie Pedersen.
Bankruptcy risk for EJP PHARMACEUTICAL ApS
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 87923614
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (44 years)
- Address
- Skodsborgparken 14, 3. th
2942 Skodsborg - Municipality
- Rudersdal
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 200k
- Employees
- 1 (2006)
- Auditor
- JS Revision Godkendt Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 30 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 90.9% |
| Current ratio | 1,101% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 2 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -28k | DKK -33k | DKK -34k |
| Net profit | DKK 214k | DKK 414k | DKK 454k |
| Equity | DKK 814k | DKK 4.4m | DKK 4.1m |
| Total assets | DKK 896k | DKK 4.5m | DKK 4.2m |
| Cash | DKK 133k | DKK 214k | – |
| Short-term debt | DKK 81k | DKK 84k | – |
| Tax owed | DKK 58k | DKK 61k | – |
| Avg. employees | 0 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · JS Revision Godkendt Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 117 | ||
| 1 Jan 2024 – 31 Dec 2024 | 175 | ||
| 1 Jan 2023 – 31 Dec 2023 | 128 | ||
| 1 Jan 2022 – 31 Dec 2022 | 87 | ||
| 1 Jan 2021 – 31 Dec 2021 | 151 | ||
| 1 Jan 2020 – 31 Dec 2020 | 95 | ||
| 1 Jan 2019 – 31 Dec 2019 | 87 | ||
| 1 Jan 2018 – 31 Dec 2018 | 144 | ||
| 1 Jan 2017 – 31 Dec 2017 | 75 | ||
| 1 Jan 2016 – 31 Dec 2016 | 138 | ||
| 1 Jan 2015 – 31 Dec 2015 | 148 | ||
| 1 Jan 2014 – 31 Dec 2014 | 149 | ||
| 1 Jan 2013 – 31 Dec 2013 | 162 | ||
| 1 Jan 2012 – 31 Dec 2012 | 143 | ||
| 1 Jan 2011 – 31 Dec 2011 | 157 | ||
| 1 Jan 2010 – 31 Dec 2010 | 125 | ||
| 1 Jan 2009 – 31 Dec 2009 | 152 | ||
| 1 Jan 2008 – 31 Dec 2008 | 155 | ||
| 1 Jan 2007 – 31 Dec 2007 | 153 | ||
| 1 Jan 2006 – 31 Dec 2006 | 176 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ejvind Jersie Pedersen | Current | |
| Owner (100%) | Ejvind Jersie Pedersen | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | BEIERHOLM, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S | ||
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S |
The CEOs' other companies
Ejvind Jersie Pedersen – 8 other companies, of which 2 bankrupt
- CONSULT PHARMA A/S Bankrupt 12 Jul 1988
- JEMO-PHARM A/S Bankrupt 17 May 1988
- EP PHARMACEUTICALS ApS Fusioneret
- HALICARE ApS Active
- JEMO PHARM EJENDOMSSELSKAB ApS Fusioneret
- JEMO-PHARM A/S Active
- SALMED ApS Fusioneret
- VITA CARE A/S Fusioneret
Address history (4 moves)
| Skodsborgparken 14, 3. th, 2942 Skodsborg | |
| Skodsborgparken 14, 3. th, 2942 Skodsborg | |
| Ulvshalevej 70A, 4780 Stege | |
| Ulvshalevej 70A, 4780 Stege | |
| Hasselvej 1, 4780 Stege |
Former names
| EJP PHARMACEUTICAL ApS | – now |
| JEMO-PHARM HOLDING ApS | – |
Employees per year
Other companies at the same address
- BRIXEN & BRIXEN ApS Opløst
- HALICARE ApS Active
- HBS ApS Active
Similar companies in Rudersdal
- RAMAS INTERNATIONAL A/S Holte
- OSVALD JENSEN HOLDING A/S Vedbæk
- MISP HOLDING A/S Vedbæk
- F. WEIEN SVENDSEN HOLDING A/S Holte
- UNION ApS Vedbæk
- BP & CO. HOLDING ApS Holte
- SPELLERBERG HOLDING ApS Vedbæk
- PROVINORD A/S Holte
- AANDAHL A/S Vedbæk
- LIND JACOBSEN HOLDING ApS Holte
- SCAN-CENTER 2000 HOLDING A/S Vedbæk
- SCANDI-LINK HOLDING ApS Holte
Questions and answers about EJP PHARMACEUTICAL ApS
Has EJP PHARMACEUTICAL ApS gone bankrupt?
No, EJP PHARMACEUTICAL ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of EJP PHARMACEUTICAL ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of EJP PHARMACEUTICAL ApS?
Ejvind Jersie Pedersen is the CEO of EJP PHARMACEUTICAL ApS.
Who is the auditor of EJP PHARMACEUTICAL ApS?
EJP PHARMACEUTICAL ApS most recently used JS Revision Godkendt Revisionsaktieselskab.
When was EJP PHARMACEUTICAL ApS founded?
EJP PHARMACEUTICAL ApS was founded on 18 February 1982.
What is the equity of EJP PHARMACEUTICAL ApS?
Equity was DKK 814k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.